3ktm › Citations

Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein.

Dahms SO, Hoefgen S, Roeser D, Schlott B, Gührs KH, Than ME
Proc Natl Acad Sci U S A 107 5381-6 (2010)
Cited: 68 times
EuropePMC logo PMID: 20212142

Abstract

The amyloid precursor protein (APP) is the key player in Alzheimer's disease pathology, yet APP and its analogues are also essential for neuronal development and cell homeostasis in mammals. We have determined the crystal structure of the entire N-terminal APP-E1 domain consisting of the growth factor like and the copper binding domains at 2.7-A resolution and show that E1 functions as a rigid functional entity. The two subdomains interact tightly in a pH-dependent manner via an evolutionarily conserved interface area. Two E1 entities dimerize upon their interaction with heparin, requiring 8-12 sugar rings to form the heparin-bridged APP-E1 dimer in an endothermic and pH-dependent process that is characterized by a low micromolar dissociation constant. Limited proteolysis confirms that the heparin-bridged E1 dimers obtained in solution correspond to a dimer contact in our crystal, enabling us to model this heparin-[APP-E1](2) complex. Correspondingly, the APP-based signal transduction, cell-cell- and/or cell-ECM interaction should depend on dimerization induced by heparin, as well as on pH, arguing that APP could fulfill different functions depending on its (sub)cellular localization.

Reviews - 3ktm mentioned but not cited (5)

  1. Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease. Dawkins E, Small DH. J Neurochem 129 756-769 (2014)
  2. Structural aspects and physiological consequences of APP/APLP trans-dimerization. Baumkötter F, Wagner K, Eggert S, Wild K, Kins S. Exp Brain Res 217 389-395 (2012)
  3. Alzheimer's disease--a panorama glimpse. Zhao LN, Lu L, Chew LY, Mu Y. Int J Mol Sci 15 12631-12650 (2014)
  4. Invasive and non-invasive therapies for Alzheimer's disease and other amyloidosis. Pandey G, Ramakrishnan V. Biophys Rev 12 1175-1186 (2020)
  5. Structural biology of cell surface receptors implicated in Alzheimer's disease. Hermans SJ, Nero TL, Morton CJ, Gooi JH, Crespi GAN, Hancock NC, Gao C, Ishii K, Markulić J, Parker MW. Biophys Rev 14 233-255 (2022)

Articles - 3ktm mentioned but not cited (11)

  1. Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein. Dahms SO, Hoefgen S, Roeser D, Schlott B, Gührs KH, Than ME. Proc Natl Acad Sci U S A 107 5381-5386 (2010)
  2. Amyloid precursor protein dimerization and synaptogenic function depend on copper binding to the growth factor-like domain. Baumkötter F, Schmidt N, Vargas C, Schilling S, Weber R, Wagner K, Fiedler S, Klug W, Radzimanowski J, Nickolaus S, Keller S, Eggert S, Wild K, Kins S. J Neurosci 34 11159-11172 (2014)
  3. Analysis of the overall structure of the multi-domain amyloid precursor protein (APP). Coburger I, Dahms SO, Roeser D, Gührs KH, Hortschansky P, Than ME. PLoS One 8 e81926 (2013)
  4. Genomic Footprints in Selected and Unselected Beef Cattle Breeds in Korea. Lim D, Strucken EM, Choi BH, Chai HH, Cho YM, Jang GW, Kim TH, Gondro C, Lee SH. PLoS One 11 e0151324 (2016)
  5. Packing Density of the Amyloid Precursor Protein in the Cell Membrane. de Coninck D, Schmidt TH, Schloetel JG, Lang T. Biophys J 114 1128-1141 (2018)
  6. Members of the vertebrate contactin and amyloid precursor protein families interact through a conserved interface. Karuppan SJ, Vogt A, Fischer Z, Ladutska A, Swiastyn J, McGraw HF, Bouyain S. J Biol Chem 298 101541 (2022)
  7. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  8. TIMP-1 is a novel ligand of Amyloid Precursor Protein and triggers a proinflammatory phenotype in human monocytes. Eckfeld C, Schoeps B, Häußler D, Frädrich J, Bayerl F, Böttcher JP, Knolle P, Heisz S, Prokopchuk O, Hauner H, Munkhbaatar E, Demir IE, Hermann CD, Krüger A. J Cell Biol 222 e202206095 (2023)
  9. From EST to structure models for functional inference of APP, BACE1, PSEN1, PSEN2 genes. Aathi M, Piramanayagam S. Bioinformation 15 760-771 (2019)
  10. Structural Basis for PPARs Activation by The Dual PPARα/γ Agonist Sanguinarine: A Unique Mode of Ligand Recognition. Tian S, Wang R, Chen S, He J, Zheng W, Li Y. Molecules 26 6012 (2021)
  11. The Clinical Efficiency and the Mechanism of Sanzi Yangqin Decoction for Chronic Obstructive Pulmonary Disease. Wang M, Gu W, Kui F, Gao F, Niu Y, Li W, Zhang Y, Guo L, Geng S, Du G. Evid Based Complement Alternat Med 2021 5565562 (2021)


Reviews citing this publication (16)

  1. Demystifying heparan sulfate-protein interactions. Xu D, Esko JD. Annu Rev Biochem 83 129-157 (2014)
  2. Not just amyloid: physiological functions of the amyloid precursor protein family. Müller UC, Deller T, Korte M. Nat Rev Neurosci 18 281-298 (2017)
  3. Proteolytic processing of Alzheimer's β-amyloid precursor protein. Zhang H, Ma Q, Zhang YW, Xu H. J Neurochem 120 Suppl 1 9-21 (2012)
  4. Physiological functions of APP family proteins. Müller UC, Zheng H. Cold Spring Harb Perspect Med 2 a006288 (2012)
  5. Applications of isothermal titration calorimetry in pure and applied research--survey of the literature from 2010. Ghai R, Falconer RJ, Collins BM. J Mol Recognit 25 32-52 (2012)
  6. Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease. Habib A, Sawmiller D, Tan J. J Neurosci Res 95 973-991 (2017)
  7. Roles of the amyloid precursor protein family in the peripheral nervous system. Caldwell JH, Klevanski M, Saar M, Müller UC. Mech Dev 130 433-446 (2013)
  8. The Role of APP in Structural Spine Plasticity. Montagna E, Dorostkar MM, Herms J. Front Mol Neurosci 10 136 (2017)
  9. Matrikines and the lungs. Burgess JK, Weckmann M. Pharmacol Ther 134 317-337 (2012)
  10. Platelets and Alzheimer's disease: Potential of APP as a biomarker. Evin G, Li QX. World J Psychiatry 2 102-113 (2012)
  11. Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease. Bignante EA, Heredia F, Morfini G, Lorenzo A. Neurobiol Aging 34 2525-2537 (2013)
  12. Proteomic analysis of the presynaptic active zone. Volknandt W, Karas M. Exp Brain Res 217 449-461 (2012)
  13. Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding. Scharfenberg F, Armbrust F, Marengo L, Pietrzik C, Becker-Pauly C. Cell Mol Life Sci 76 3193-3206 (2019)
  14. Structural Determinant of β-Amyloid Formation: From Transmembrane Protein Dimerization to β-Amyloid Aggregates. Papadopoulos N, Suelves N, Perrin F, Vadukul DM, Vrancx C, Constantinescu SN, Kienlen-Campard P. Biomedicines 10 2753 (2022)
  15. Amyloid precursor protein and its interacting proteins in neurodevelopment. Chau DD, Ng LL, Zhai Y, Lau KF. Biochem Soc Trans 51 1647-1659 (2023)
  16. Cholesterol-dependent amyloid β production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol. Rudajev V, Novotny J. Cell Biosci 13 171 (2023)

Articles citing this publication (36)

  1. Biology and pathophysiology of the amyloid precursor protein. Zheng H, Koo EH. Mol Neurodegener 6 27 (2011)
  2. APP homodimers transduce an amyloid-β-mediated increase in release probability at excitatory synapses. Fogel H, Frere S, Segev O, Bharill S, Shapira I, Gazit N, O'Malley T, Slomowitz E, Berdichevsky Y, Walsh DM, Isacoff EY, Hirsch JA, Slutsky I. Cell Rep 7 1560-1576 (2014)
  3. Brain endothelial cells produce amyloid {beta} from amyloid precursor protein 770 and preferentially secrete the O-glycosylated form. Kitazume S, Tachida Y, Kato M, Yamaguchi Y, Honda T, Hashimoto Y, Wada Y, Saito T, Iwata N, Saido T, Taniguchi N. J Biol Chem 285 40097-40103 (2010)
  4. Metal binding dictates conformation and function of the amyloid precursor protein (APP) E2 domain. Dahms SO, Könnig I, Roeser D, Gührs KH, Mayer MC, Kaden D, Multhaup G, Than ME. J Mol Biol 416 438-452 (2012)
  5. Identification of NEEP21 as a ß-amyloid precursor protein-interacting protein in vivo that modulates amyloidogenic processing in vitro. Norstrom EM, Zhang C, Tanzi R, Sisodia SS. J Neurosci 30 15677-15685 (2010)
  6. Structural features of the KPI domain control APP dimerization, trafficking, and processing. Ben Khalifa N, Tyteca D, Marinangeli C, Depuydt M, Collet JF, Courtoy PJ, Renauld JC, Constantinescu S, Octave JN, Kienlen-Campard P. FASEB J 26 855-867 (2012)
  7. Shedding of APP limits its synaptogenic activity and cell adhesion properties. Stahl R, Schilling S, Soba P, Rupp C, Hartmann T, Wagner K, Merdes G, Eggert S, Kins S. Front Cell Neurosci 8 410 (2014)
  8. N-cadherin enhances APP dimerization at the extracellular domain and modulates Aβ production. Asada-Utsugi M, Uemura K, Noda Y, Kuzuya A, Maesako M, Ando K, Kubota M, Watanabe K, Takahashi M, Kihara T, Shimohama S, Takahashi R, Berezovska O, Kinoshita A. J Neurochem 119 354-363 (2011)
  9. The E2 domains of APP and APLP1 share a conserved mode of dimerization. Lee S, Xue Y, Hu J, Wang Y, Liu X, Demeler B, Ha Y. Biochemistry 50 5453-5464 (2011)
  10. sAβPPα is a Potent Endogenous Inhibitor of BACE1. Peters-Libeu C, Campagna J, Mitsumori M, Poksay KS, Spilman P, Sabogal A, Bredesen DE, John V. J Alzheimers Dis 47 545-555 (2015)
  11. The Amyloid Precursor Protein Is a Conserved Receptor for Slit to Mediate Axon Guidance. Wang B, Li H, Mutlu SA, Bowser DA, Moore MJ, Wang MC, Zheng H. eNeuro 4 ENEURO.0185-17.2017 (2017)
  12. Identification of a novel amyloid precursor protein processing pathway that generates secreted N-terminal fragments. Vella LJ, Cappai R. FASEB J 26 2930-2940 (2012)
  13. Palmitoylated APP Forms Dimers, Cleaved by BACE1. Bhattacharyya R, Fenn RH, Barren C, Tanzi RE, Kovacs DM. PLoS One 11 e0166400 (2016)
  14. Regulation of global gene expression and cell proliferation by APP. Wu Y, Zhang S, Xu Q, Zou H, Zhou W, Cai F, Li T, Song W. Sci Rep 6 22460 (2016)
  15. Crystal structure of amyloid precursor-like protein 1 and heparin complex suggests a dual role of heparin in E2 dimerization. Xue Y, Lee S, Ha Y. Proc Natl Acad Sci U S A 108 16229-16234 (2011)
  16. Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems. Hunter S, Brayne C. Alzheimers Res Ther 4 10 (2012)
  17. The amyloid precursor protein copper binding domain histidine residues 149 and 151 mediate APP stability and metabolism. Spoerri L, Vella LJ, Pham CL, Barnham KJ, Cappai R. J Biol Chem 287 26840-26853 (2012)
  18. The full-length form of the Drosophila amyloid precursor protein is involved in memory formation. Bourdet I, Preat T, Goguel V. J Neurosci 35 1043-1051 (2015)
  19. Peptide binding by catalytic domains of the protein disulfide isomerase-related protein ERp46. Funkner A, Parthier C, Schutkowski M, Zerweck J, Lilie H, Gyrych N, Fischer G, Stubbs MT, Ferrari DM. J Mol Biol 425 1340-1362 (2013)
  20. The crystal structure of DR6 in complex with the amyloid precursor protein provides insight into death receptor activation. Xu K, Olsen O, Tzvetkova-Robev D, Tessier-Lavigne M, Nikolov DB. Genes Dev 29 785-790 (2015)
  21. The crystal structure of death receptor 6 (DR6): a potential receptor of the amyloid precursor protein (APP). Kuester M, Kemmerzehl S, Dahms SO, Roeser D, Than ME. J Mol Biol 409 189-201 (2011)
  22. Heparin induced dimerization of APP is primarily mediated by E1 and regulated by its acidic domain. Hoefgen S, Coburger I, Roeser D, Schaub Y, Dahms SO, Than ME. J Struct Biol 187 30-37 (2014)
  23. Altering APP proteolysis: increasing sAPPalpha production by targeting dimerization of the APP ectodomain. Libeu CA, Descamps O, Zhang Q, John V, Bredesen DE. PLoS One 7 e40027 (2012)
  24. Beta amyloid-induced upregulation of death receptor 6 accelerates the toxic effect of N-terminal fragment of amyloid precursor protein. Xu Y, Wang D, Luo Y, Li W, Shan Y, Tan X, Zhu C. Neurobiol Aging 36 157-168 (2015)
  25. Comparable dimerization found in wildtype and familial Alzheimer's disease amyloid precursor protein mutants. So PP, Khodr CE, Chen CD, Abraham CR. Am J Neurodegener Dis 2 15-28 (2013)
  26. Crystal structure of the E2 domain of amyloid precursor protein-like protein 1 in complex with sucrose octasulfate. Xue Y, Lee S, Wang Y, Ha Y. J Biol Chem 286 29748-29757 (2011)
  27. Evaluation of Cu(i) binding to the E2 domain of the amyloid precursor protein - a lesson in quantification of metal binding to proteins via ligand competition. Young TR, Wedd AG, Xiao Z. Metallomics 10 108-119 (2018)
  28. Computational prediction and analysis of the DR6-NAPP interaction. Ponomarev SY, Audie J. Proteins 79 1376-1395 (2011)
  29. Rapid evolution of mammalian APLP1 as a synaptic adhesion molecule. Onodera W, Asahi T, Sawamura N. Sci Rep 11 11305 (2021)
  30. The N-terminal fragment of the β-amyloid precursor protein of Alzheimer's disease (N-APP) binds to phosphoinositide-rich domains on the surface of hippocampal neurons. Dawkins E, Gasperini R, Hu Y, Cui H, Vincent AJ, Bolós M, Young KM, Foa L, Small DH. J Neurosci Res 92 1478-1489 (2014)
  31. Defining the binding interface of Amyloid Precursor Protein (APP) and Contactin3 (CNTN3) by site-directed mutagenesis. Peng X, Williams J, Smallwood PM, Nathans J. PLoS One 14 e0219384 (2019)
  32. Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce ß-amyloid in Alzheimer's disease. Dewji NN, Singer SJ, Masliah E, Rockenstein E, Kim M, Harber M, Horwood T. PLoS One 10 e0122451 (2015)
  33. A game-theoretic approach to deciphering the dynamics of amyloid-β aggregation along competing pathways. Ghosh P, Rana P, Rangachari V, Saha J, Steen E, Vaidya A. R Soc Open Sci 7 191814 (2020)
  34. APP family member dimeric complexes are formed predominantly in synaptic compartments. Schilling S, August A, Meleux M, Conradt C, Tremmel LM, Teigler S, Adam V, Müller UC, Koo EH, Kins S, Eggert S. Cell Biosci 13 141 (2023)
  35. Matriptase processing of APLP1 ectodomain alters its homodimerization. Lanchec E, Désilets A, Béliveau F, Fontaine-Carbonneau C, Laniel A, Leduc R, Lavoie C. Sci Rep 10 10091 (2020)
  36. The Drosophila homolog of APP promotes Dscam expression to drive axon terminal growth, revealing interaction between Down syndrome genes. Pizzano S, Sterne GR, Veling MW, Xu LA, Hergenreder T, Ye B. Dis Model Mech 16 dmm049725 (2023)


Quick links